1. Home
  2. SBSI vs AVDL Comparison

SBSI vs AVDL Comparison

Compare SBSI & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBSI
  • AVDL
  • Stock Information
  • Founded
  • SBSI 1960
  • AVDL 2015
  • Country
  • SBSI United States
  • AVDL Ireland
  • Employees
  • SBSI N/A
  • AVDL N/A
  • Industry
  • SBSI Major Banks
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBSI Finance
  • AVDL Health Care
  • Exchange
  • SBSI Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • SBSI 898.6M
  • AVDL 784.6M
  • IPO Year
  • SBSI N/A
  • AVDL 1996
  • Fundamental
  • Price
  • SBSI $28.90
  • AVDL $7.51
  • Analyst Decision
  • SBSI Hold
  • AVDL Strong Buy
  • Analyst Count
  • SBSI 2
  • AVDL 7
  • Target Price
  • SBSI $37.00
  • AVDL $18.86
  • AVG Volume (30 Days)
  • SBSI 118.7K
  • AVDL 792.0K
  • Earning Date
  • SBSI 04-24-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • SBSI 5.01%
  • AVDL N/A
  • EPS Growth
  • SBSI 3.19
  • AVDL N/A
  • EPS
  • SBSI 2.91
  • AVDL N/A
  • Revenue
  • SBSI $254,514,000.00
  • AVDL $169,117,000.00
  • Revenue This Year
  • SBSI $11.13
  • AVDL $50.53
  • Revenue Next Year
  • SBSI $5.41
  • AVDL $32.33
  • P/E Ratio
  • SBSI $9.95
  • AVDL N/A
  • Revenue Growth
  • SBSI 5.30
  • AVDL 504.79
  • 52 Week Low
  • SBSI $25.30
  • AVDL $7.39
  • 52 Week High
  • SBSI $38.00
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • SBSI 38.01
  • AVDL 35.31
  • Support Level
  • SBSI $28.68
  • AVDL $7.98
  • Resistance Level
  • SBSI $29.84
  • AVDL $8.31
  • Average True Range (ATR)
  • SBSI 0.48
  • AVDL 0.34
  • MACD
  • SBSI 0.04
  • AVDL -0.07
  • Stochastic Oscillator
  • SBSI 33.10
  • AVDL 5.65

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: